San Jose, CA, June 2, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced the appointment of Mr. Jinqiu (Edwards) Tang as the Chief Financial Officer of the Company, […]
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States San Jose, CA, May 26, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and […]
AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019 Continued annual revenue growth Number of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-year Continued to gain customers and increase the acceptance of our cancer risk assessment tests San Jose, CA, May 18, 2020 – AnPac Bio-Medical Science Co., […]
FOR IMMEDIATE RELEASE San Jose, CA., May 18, 2020—AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it has filed its annual report on Form 20-F for the fiscal year ended […]
FOR IMMEDIATE RELEASE AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States San Jose, CA, May 11, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening […]
AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists SAN JOSE, Calif., March 27, 2020 — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that its San […]
AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States SAN JOSE, Calif., March 24, 2020 — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance […]
FOR IMMEDIATE RELEASE AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project San Jose, CA, February 27, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that […]
San Jose, CA, February 6, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new insurance customers in China for its cancer screening and detection […]
FOR IMMEDIATE RELEASE AnPac Bio Announces Pricing of Initial Public Offering San Jose, CA, January 30, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its […]